A team at Oregon State University, working with several undergraduate students, has recorded a tiny chemical reaction that is linked to Alzheimer’s disease. Watching this reaction live could help scientists create stronger medicines in the future.
How Metals Make Brain Proteins Stick Together
The researchers used a special tool to see how certain metal ions, like copper, can make a protein called amyloid‑beta clump together. These clumps block the messages that brain cells send to each other, which is a hallmark of Alzheimer’s.
Marilyn Rampersad Mackiewicz, an associate professor of chemistry, led the study. Her group also tested tiny molecules called chelators that can grab metal ions and stop the clumping. The results were published in ACS Omega.
What Is Alzheimer’s Disease?
Alzheimer’s is the most common form of dementia. It slowly steals memory and thinking skills from millions of older adults. In the brain, amyloid‑beta proteins pile up and form clusters that break the communication highways between nerve cells.
Metals are needed for normal brain work, but too many of them can cause trouble. When copper levels rise, they can stick to amyloid‑beta and push the proteins to stick together.
Seeing the Reaction One Second at a Time
"Most experiments only show the final clump," Mackiewicz explained. "We built a method that watches each step as it happens, second by second, and measures how other molecules change the process." This lets scientists ask not just "does it work?" but also "how does it work and when?"
Testing Different Chelators
A chelator is a molecule that grabs metal ions, much like a claw. One chelator in the study caught metal ions well, but it did not pick out the specific metals that cause clumping.
A second chelator showed a strong preference for copper, the metal most linked to Alzheimer’s protein clumps. This selective binding could be useful for future treatments.
Hope for Better Treatments
Understanding exactly how protein clumps form and dissolve gives scientists a clearer map for designing medicines. While new drugs based on this work are still years away, the findings give hope that targeting the right metal could lessen brain damage.
The project also highlighted the role of undergraduate researchers. Support from the SURE Science Program and donors helped students from Oregon State and Portland State take part in the experiments.
Next, the team plans to test their observations in more complex systems, such as living cells and animal models. By watching and measuring the chemistry directly, they aim to pave the way for therapies that stop Alzheimer’s before it spreads.